Association of metabolic factors with high-sensitivity C-reactive protein in patients with sleep-disordered breathing

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 2, 2013, Pages 749-754

  Su, Mao Chang ^a,b,c   Chen, Yung Che ^a,b   Huang, Kuo Tung ^a,b   Wang, Chin Chou ^a,c   Lin, Meng Chih ^a,b,c   Lin, Hsin Ching ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Cardiovascular risk; High sensitivity C reactive protein; Metabolic syndrome; Sleep disordered breathing

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL ESTER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; EPWORTH SLEEPINESS SCALE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NECK CIRCUMFERENCE; OXYGEN DESATURATION; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SLEEP STAGE; SLEEP TIME; SMOKING; SNORING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES COMPLICATIONS; FEMALE; HUMANS; LIPIDS; MALE; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; SMOKING;

EID: 84878355190     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2191-4     Document Type: Article

References (28)

1. Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053
2. Bradley TD, Floras JS (2009) Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82-93
3. Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American heart association/American college of cardiology foundation scientific statement from the American heart association council for high blood pressure research professional education committee, council on clinical cardiology, stroke council, and council on cardiovascular nursing. J Am Coll Cardiol 52:686-717
4. Corrado E, Rizzo M, Coppola G et al (2010) An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 17:1-11
5. Ridker PM (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 49:2129-2138
6. Peled N, Kassirer M, Shitrit D et al (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 101:1696-1701
7. Lee LA, Chen NH, Huang CG et al (2010) Patients with severe obstructive sleep apnea syndrome and elevated high-sensitivity C-reactive protein need priority treatment. Otolaryngol Head Neck Surg 143:72-77
8. Saletu M, Nosiska D, Kapfhammer G et al (2006) Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J Neurol 253:746-752
9. Hu G, Qiao Q, Tuomilehto J (2005) The metabolic syndrome and cardiovascular risk. Curr Diabetes Rev 1:137-143
10. Ardern CI, Janssen I (2007) Metabolic syndrome and its association with morbidity and mortality. Appl Physiol Nutr Metab 32:33-45
11. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
12. Chen NH, Johns MW, Li HY et al (2002) Validation of a Chinese version of the Epworth sleepiness scale. Qual Life Res 11:817-821
13. Kushida CA, Littner MR, Morgenthaler T et al (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28:499-521
14. Arnardottir ES, Mackiewicz M, Gislason T et al (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32:447-470
15. Drager LF, Bortolotto LA, Krieger EM et al (2009) Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 53:64-69
16. Jelic S, Le Jemtel TH (2008) Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 18:253-260
17. Calhoun DA, Harding SM (2010) Sleep and hypertension. Chest 138:434-443
18. Sorajja D, Gami AS, Somers VK et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133:927-933
19. Yumino D, Wang H, Floras JS et al (2009) Prevalence and physiological predictors of sleep apnea in patients with heart failure and systolic dysfunction. J Card Fail 15:279-285
20. Arzt M, Young T, Finn L et al (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172:1447-1451
21. Lozano L, Tovar JL, Sampol G et al (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28:2161-2168
22. de Lima AM, Franco CM, de Castro CM et al (2010) Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 79:370-376
23. Sharma SK, Mishra HK, Sharma H et al (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9:149-156
24. Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676
25. Tan KC, Chow WS, Lam JC et al (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377-382
26. Savransky V, Nanayakkara A, Li J et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175:1290-1297
27. Trombetta IC, Somers VK, Maki-Nunes C et al (2010) Consequences of comorbid sleep apnea in the metabolic syndrome-implications for cardiovascular risk. Sleep 33:1193-1199
28. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 64:631-636